Healthcare Update

Vermilion Compass: Weekly Equity Strategy

SPX Testing Resistance as Rate Cut Cycle Begins The S&P 500 (SPX) is back to test YTD highs and important resistance in the 5670-5783 range. This is an important target/resistance area we have discussed for weeks; using the 2007 SPX topping analog which has tracked the current market almost perfectly, it would suggest a 2% or less move above the prior all-time high set in July at 5670 before topping, which is where we get the 5783 number. As long as the SPX does not have a weekly close above 57...

Vermilion Compass: Weekly Equity Strategy

Upgrading Consumer Staples, Real Estate, and Health Care to Overweight; List of Concerns Continues to Grow Our long-term outlook remains neutral on the S&P 500 (SPX) as of our 8/6/24 Compass, after being bullish since early-November 2023. In late-July (7/30/24 Compass) we discussed expectations for a 1- to 4-month pullback/consolidation period on the SPX and Nasdaq 100 (QQQ), and at this point it seems likely to last closer to four months, and potentially 4- to 6-months from our selected 7/17/2...

HCA Healthcare, Inc. - June 2024 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's Ratings assigns Baa3 rating to HCA Inc.'s proposed senior unse...

Moody's Ratings (Moodys) assigned a Baa3 rating to HCA Inc.'s ("HCA") proposed offering of backed senior unsecured notes due 2034 and 2054. The Company also proposed a fungible add-on to the 5.45% 2031 backed senior unsecured notes. HCA intends to use the net proceeds from this offering for repaymen...

HCA Healthcare Inc: 2 directors

Two Directors at HCA Healthcare Inc sold/sold after exercising options 8,165 shares at between 359.962USD and 363.510USD. The significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all...

Vermilion Compass: Weekly Equity Strategy

Upgrading Health Care to Market Weight Breadth continues to improve and Russell 2000 (IWM) small-caps and the Dow remain bullish, all while the S&P 500 and Nasdaq 100 (QQQ) are going through a pullback/consolidation phase. Considering the Russell 2000 vs. S&P 500 ratio is reversing a 3.5-year downtrend, we expect this trend of small-cap outperformance to continue for months or longer. We will maintain our bullish view on small-caps (IWM) and the Dow as long as they remain above $210 and 39,800,...

HCA Healthcare, Inc. - March 2024 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

HCA Inc.: Update to credit analysis

Our credit view of this issuer reflects its significant scale and strong free cash flow, constrained by its uncertainty impacting reimbursements and its ongoing impact from high labor costs.

HCA Healthcare, Inc. - December 2023 (LTM): Peer Snapshot 

Compares key performance metrics against industry peers.

Vermilion Compass: Weekly Equity Strategy

Small Caps Outperform Despite "Hot" Inflation Reports In spite of last week's hotter-than-expected inflation reports (CPI and PPI), the S&P 500 remains above its 20-day MA, and, more notably, the Russell 2000 (IWM) outperformed relative to the SPX and QQQ, and ended the week at YTD weekly closing highs. Small-caps are supposed to fall and/or underperform if inflation is on the rise. When stocks do the opposite of what is expected of them, that is valuable information. The fact that small- and m...

Moody's assigns Baa3 rating to HCA Inc.'s proposed senior unsecured no...

Moody's Investors Service ("Moody's") assigned a Baa3 rating to HCA Inc.'s ("HCA" or "the company") proposed offering of backed senior unsecured notes. HCA intends to use the net proceeds from this offering for repayment of ner-term maturities and for general corporate purposes. Prior to that, the c...

Vermilion Compass: Weekly Equity Strategy

Monitoring Rising Treasury Yields & U.S. Dollar (DXY) The Fed wanting "greater confidence" that inflation is sustainably moving toward its 2% target signals a patient approach with respect to rate cuts, meaning a more restrictive policy than the market expected. This is disproportionately hitting small- and mid-caps which are more sensitive to higher interest rates. This suggests we could see further consolidation for small- and mid-caps, while large-cap indexes (S&P 500, Nasdaq 100, DJI) remai...

HCA Healthcare, Inc. - September 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

HCA Healthcare, Inc. - June 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Depth Check - HCA 2Q ’23 Earnings

HCA Inc.: Update to credit analysis

Our credit view of this issuer reflects its significant scale and strong free cash flow, constrained by ongoing impact from high labor cost.

HCA Healthcare ($HCA) Again

HCA Healthcare, Inc. - March 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's assigns Baa3 rating to HCA Inc.'s proposed senior unsecured no...

Moody's Investors Service ("Moody's") assigned a Baa3 rating to HCA Inc.'s ("HCA" or "the company") proposed offering of senior unsecured notes. HCA intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of borrowings outstanding under its ...